PEMETREXED for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 2,422 adverse event reports in the FDA FAERS database where PEMETREXED was used for Lung neoplasm malignant.
Most Reported Side Effects for PEMETREXED
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 2,149 | 9.1% | 613 | 587 |
| Off label use | 1,663 | 7.1% | 308 | 652 |
| Anaemia | 1,430 | 6.1% | 173 | 745 |
| Pancytopenia | 1,236 | 5.3% | 286 | 861 |
| Neutropenia | 1,200 | 5.1% | 212 | 505 |
| Nausea | 1,195 | 5.1% | 164 | 579 |
| Diarrhoea | 1,165 | 5.0% | 273 | 706 |
| Acute kidney injury | 1,105 | 4.7% | 169 | 773 |
| Thrombocytopenia | 1,059 | 4.5% | 195 | 540 |
| Disease progression | 969 | 4.1% | 184 | 134 |
| Vomiting | 903 | 3.8% | 149 | 548 |
| Fatigue | 867 | 3.7% | 91 | 305 |
| Febrile neutropenia | 852 | 3.6% | 250 | 574 |
| Drug ineffective | 838 | 3.6% | 179 | 206 |
| Death | 808 | 3.4% | 807 | 187 |
Other Indications for PEMETREXED
Non-small cell lung cancer (5,179)
Lung adenocarcinoma (4,280)
Product used for unknown indication (1,640)
Lung adenocarcinoma stage iv (1,510)
Non-small cell lung cancer metastatic (1,426)
Non-small cell lung cancer stage iv (782)
Bronchial carcinoma (712)
Pleural mesothelioma malignant (427)
Adenocarcinoma (374)
Lung cancer metastatic (308)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)
ATEZOLIZUMAB (1,262)